Wells Fargo Maintains Equal-Weight on United Therapeutics, Raises Price Target to $466

United Therapeutics Corporation +7.70%

United Therapeutics Corporation

UTHR

514.98

+7.70%

Wells Fargo analyst Benjamin Burnett maintains United Therapeutics (NASDAQ: UTHR) with a Equal-Weight and raises the price target from $423 to $466.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via